| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2022 - PRIN bando 2022 |
Dissecting the pharmacological mechanisms underlying the therapeutic potential of phytocannabinoids in autism
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
The role of TRPM8 and its dietary ligands in intestinal fibrosis: a translational exploration
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
DEVELOPMENTAL ROLE OF THE MUTANT ANDROGEN RECEPTOR CAUSATIVE OF SPINAL AND BULBAR MUSCULAR ATROPHY (SBMA)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
STRESS AND PSYCHOPATHOLOGIC DOMAINS: FROM MOLECULAR MECHANISMS TO BRAIN CIRCUITS
|
|
Ongoing | 2023 |
| INTLI - Finanziamenti internazionali |
The involvement of the small heat shock protein HSPB8 in amyotrophic lateral sclerosis (2° annualità)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Supporting medication adherence by the Elderly: development of an action framework for different healthcare settings
|
|
Ongoing | 2023 |
| Horizon Europe - Marie Skłodowska-Curie actions - Doctoral Networks (DN) |
Breaking the barrier -An integrated multidisciplinary approach to killGram-negative bacteria through existing antibiotics by making their outer membrane permeable (BREAKthrough)
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Evaluation of Castanea sativa by-products as a source of bioactive molecules against Helicobacter pylori-induced inflammation: a novel sustainable strategy Acronym: CastACTIVE
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Adoptive cell transfer of metabolic reprogrammed T regulatory cells to control atherosclerosis progression and to prevent end organ damage in cardiovascular disease.
|
|
Ongoing | 2023 |
| FON_NAZ - Bandi Altre Fondazioni |
Linking inflammation to progression of neurodegeneration in Parkinson’s disease (LINKING PARK)
|
|
Ongoing | 2023 |
